Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis.

Besada E, Koldingsnes W, Nossent JC.

PeerJ. 2015 Jun 25;3:e1051. doi: 10.7717/peerj.1051. eCollection 2015.

2.

Chronic nasal Staphylococcus aureus carriage identifies a subset of newly diagnosed granulomatosis with polyangiitis patients with high relapse rate.

Salmela A, Rasmussen N, Tervaert JWC, Jayne DRW, Ekstrand A; European Vasculitis Study Group.

Rheumatology (Oxford). 2017 Jun 1;56(6):965-972. doi: 10.1093/rheumatology/kex001.

PMID:
28339745
3.

Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.

Calich AL, Puéchal X, Pugnet G, London J, Terrier B, Charles P, Mouthon L, Guillevin L; French Vasculitis Study Group.

J Autoimmun. 2014 May;50:135-41. doi: 10.1016/j.jaut.2014.03.002. Epub 2014 Apr 2.

PMID:
24703438
4.

No evident association of nasal carriage of Staphylococcus aureus or its small-colony variants with cotrimoxazole use or ANCA-associated vasculitis relapses.

Tan BK, Crabol Y, Tasse J, Laurent F, Nekkab N, Vinter C, Puéchal X, Guillevin L.

Rheumatology (Oxford). 2020 Jan 1;59(1):77-83. doi: 10.1093/rheumatology/kez236.

PMID:
31834404
5.

Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre.

Besada E, Koldingsnes W, Nossent JC.

Rheumatology (Oxford). 2013 Nov;52(11):2041-7. doi: 10.1093/rheumatology/ket257. Epub 2013 Aug 11.

PMID:
23934313
6.

Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis.

Besada E, Koldingsnes W, Nossent JC.

Rheumatology (Oxford). 2014 Oct;53(10):1818-24. doi: 10.1093/rheumatology/keu194. Epub 2014 May 15.

PMID:
24831059
7.

CD4 cell count and CD4/CD8 ratio increase during rituximab maintenance in granulomatosis with polyangiitis patients.

Besada E, Nossent JC.

PeerJ. 2016 Sep 20;4:e2487. doi: 10.7717/peerj.2487. eCollection 2016.

8.

Rituximab maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis.

Roubaud-Baudron C, Pagnoux C, Méaux-Ruault N, Grasland A, Zoulim A, LE Guen J, Prud'homme A, Bienvenu B, de Menthon M, Camps S, LE Guern V, Aouba A, Cohen P, Mouthon L, Guillevin L; French Vasculitis Study Group.

J Rheumatol. 2012 Jan;39(1):125-30. doi: 10.3899/jrheum.110143. Epub 2011 Nov 15.

PMID:
22089465
9.

Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.

Cartin-Ceba R, Golbin JM, Keogh KA, Peikert T, Sánchez-Menéndez M, Ytterberg SR, Fervenza FC, Specks U.

Arthritis Rheum. 2012 Nov;64(11):3770-8. doi: 10.1002/art.34584.

10.
11.
12.
13.

Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients.

Puéchal X, Iudici M, Calich AL, Vivot A, Terrier B, Régent A, Cohen P, Jeunne CL, Mouthon L, Ravaud P, Guillevin L.

Rheumatology (Oxford). 2019 Mar 1;58(3):401-409. doi: 10.1093/rheumatology/key117.

PMID:
29722877
14.
15.

Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab.

Cartin-Ceba R, Fervenza FC, Specks U.

Curr Opin Rheumatol. 2012 Jan;24(1):15-23. doi: 10.1097/BOR.0b013e32834d5730. Review.

PMID:
22089095
16.

Relapsing granulomatosis with polyangiitis with severe lung and upper respiratory tract involvement successfully treated with rituximab.

Masiak A, Zdrojewski Z.

Reumatologia. 2017;55(4):208-212. doi: 10.5114/reum.2017.69783. Epub 2017 Aug 31.

17.

The composition and functional protein subsystems of the human nasal microbiome in granulomatosis with polyangiitis: a pilot study.

Wagner J, Harrison EM, Martinez Del Pero M, Blane B, Mayer G, Leierer J, Gopaluni S, Holmes MA, Parkhill J, Peacock SJ, Jayne DRW, Kronbichler A.

Microbiome. 2019 Oct 22;7(1):137. doi: 10.1186/s40168-019-0753-z.

18.

The presence of staphylococcal superantigens in nasal swabs and correlation with activity of granulomatosis with polyangiitis in own material.

Fijołek J, Wiatr E, Petroniec V, Augustynowicz-Kopec E, Bednarek M, Gawryluk D, Martusewicz-Boros MM, Modrzewska K, Radzikowska E, Roszkowski-Sliz K.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):40-45. Epub 2018 May 4.

19.

The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study.

Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Radin M, Fenoglio R, Baldovino S, Menegatti E.

Oncotarget. 2017 May 23;8(32):52072-52077. doi: 10.18632/oncotarget.18120. eCollection 2017 Aug 8.

20.

Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis.

Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG.

Ann Intern Med. 1994 Jan 1;120(1):12-7.

PMID:
8250451

Supplemental Content

Support Center